Boston, MA 06/03/2013 (wallstreetpr) – The share prices of Therapeutics MD Inc. (NYSEMKT:TXMD) had gained 10.71 percent to close at $2.79 per share for the end of last trading session on Friday. The shares of the company had been trading in the range of $2.45 to $2.79 per share during the day. The shares of Therapeutics MD Inc. (NYSEMKT:TXMD) had recorded 52 week low price level of $1.25 per share and 52 week high price level of $3.70 per share.
Therapeutics MD Inc. (NYSEMKT:TXMD) is involved in the promotion, distribution and selling of few products of Spectrum Health Network Inc relative to its digital media network. The company is presently in a licensing agreement with Spectrum Health Network through which it focuses on multispecialty group practices and independent physician associations for selling to them software, hardware and content developed by Spectrum Networks.
The women’s healthcare company, Therapeutics MD Inc. (NYSEMKT:TXMD) would be presenting at the Jefferies Global Healthcare conference to be held at the New York City on June 03 – 06, 2013. Further, the company had recently elected a former senior executive at Johnson & Johnson to its board of directors with immediate effect. Jules A. Musing, elected to the board, has more than 36 years of experience in the pharmaceutical and bio technology industry.
Therapeutics MD Inc. (NYSEMKT:TXMD) presently holds 99.78 million shares outstanding with an institutional ownership of 29 percent of its holdings. The company had witnessed nearly 127,459 shares being traded on Friday, while the average trading volume of Therapeutics MD Inc. (NYSEMKT:TXMD) is at 134,138 shares per day.
